Latest Breaking News On - Director victoria vakiener - Page 1 : vimarsana.com

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Down 2 6%

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report)’s stock price dropped 2.6% on Tuesday . The stock traded as low as $24.24 and last traded at $24.24. Approximately 37,306 shares changed hands during trading, a decline of 97% from the average daily volume of 1,348,370 shares. The stock had previously closed at $24.88. Analyst Ratings […]

United statesHongbo luNews ratings for arrowhead pharmaceuticals dailyInvesco ltdAvoro capital advisorsArrowhead pharmaceuticals incInsider activity at arrowhead pharmaceuticalsArrowhead pharmaceuticalsSecurities exchange commissionVanguard group incNorges bankMorgan stanleyRoyal bankArrowhead pharmaceuticals price performanceGet free reportChardan capital

HC Wainwright Reiterates Buy Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)

HC Wainwright reaffirmed their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research report released on Monday, Benzinga reports. They currently have a $90.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Arrowhead Pharmaceuticals’ FY2028 earnings at $0.43 EPS. A number of other equities analysts […]

United statesHongbo luArrowhead pharmaceuticalsArrowhead pharmaceuticals price performanceSecurities exchange commissionCanada life assuranceArrowhead pharmaceuticals incInstitutional trading of arrowhead pharmaceuticalsPricet rowe associates incAvoro capital advisorsInsider transactions at arrowhead pharmaceuticalsMorgan stanleyNews ratings for arrowhead pharmaceuticals dailyAnalyst recommendations for arrowhead pharmaceuticalsRoyal bankAffinity asset advisors

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Up 7 4%

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Up 7 4%
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesHudson bayHongbo luMorgan stanleyArrowhead pharmaceuticals stockCitigroup incArrowhead pharmaceuticalsRoyal bankInvesco ltdInstitutional trading of arrowhead pharmaceuticalsArrowhead pharmaceuticals incNews ratings for arrowhead pharmaceuticals dailyGet free reportDirector victoria vakienerHudson bay capital managementBay capital management

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target Lowered to $27 00 at Morgan Stanley

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target Lowered to $27 00 at Morgan Stanley
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Hudson bayUnited statesKenneth allen myszkowskiMorgan stanleyArrowhead pharmaceuticals stock performanceArrowhead pharmaceuticals incInstitutional trading of arrowhead pharmaceuticalsInsider transactions at arrowhead pharmaceuticalsAnalyst recommendations for arrowhead pharmaceuticalsNews ratings for arrowhead pharmaceuticals dailyArrowhead pharmaceuticalsSecurities exchange commissionRoyal bankInvesco ltdCitigroup incFree report

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Releases Quarterly Earnings Results, Misses Estimates By $0 96 EPS

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Releases Quarterly Earnings Results, Misses Estimates By $0 96 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesKenneth allen myszkowskiArrowhead pharmaceuticals incSecurities exchange commissionEarnings history for arrowhead pharmaceuticalsArrowhead pharmaceuticals company profileRoyal bankNews ratings for arrowhead pharmaceuticals dailyArrowhead pharmaceuticalsArrowhead pharmaceuticals price performanceMorgan stanleyGet free reportDirector victoria vakienerAllen myszkowskiExchange commissionArrowhead pharmaceuticals daily